DRUG INTERACTIONS AND BIOAVAILABILITY OF CRANBERRY FLAVANOIDS

蔓越莓黄酮的药物相互作用和生物利用度

• 批准号: 7719586
• 负责人: JENNIFER L DONOVAN
• 金额: $ 3.29万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-05-01 至 2009-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7719586
• 关键词: Affect; Biological Availability; Blood; Chemicals; Computer Retrieval of Information on Scientific Projects Database; Cranberries; Drug Interactions; Excretory function; Funding; General Population; Goals; Grant; Institution; Juice; Metabolism; Pharmaceutical Preparations; Powder dose form; Purpose; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Urinary tract infection; Urine; flavanoid; prescription document; prescription procedure

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is sponsored by NIH/NCCAM. It is known that cranberry juice and powders are being used by the general public as alternative medication to treat urinary tract infections and for other purposes. Cranberry juice and powders contain large quantities of natural chemicals called flavanoids. One of the goals of this study is to determine the concentrations of flavanoids in blood and urine after a large serving of cranberry juice is ingested. Another goal is to determine if taking a cranberry powder will affect the breakdown and excretion (metabolism) of other prescription medications when cranberry powder is taken together with these medications.

这个子项目是众多研究子项目之一